Last updated on November 2017

A Phase 3, Multicenter, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis.


Brief description of study

A Phase 3, Multicenter, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis.

Detailed Study Description

The Primary Objective if this study is to evaluate the efficacy of SHP640 based on clinical resolution (Defined as absence of bulbar conjunctival injection and ocular conjunctival discharge) compared with placebo in the treatment of subject with Bacterial Conjunctivitis in the study at Visit 3(Day5).

Clinical Study Identifier: TX14841

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kellye Johnson

The Eye Care Institute
Louisville, KY USA
  Connect »